RocheHeadquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2009, Roche had over 80'000 employees worldwide and invested almost 10 billion Swiss francs in R&D. The Group posted sales of 49.1 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information:

Roche RSS Channel

Title Filter      Display #  
# Article Title
1 Roche again ranked most sustainable healthcare company in the Dow Jones Sustainability Indices
2 Roche and InterMune reach definitive merger agreement
3 FDA approves Roche's Avastin plus chemotherapy for treatment of advanced cervical cancer
4 Roche to acquire Santaris Pharma to expand discovery and development of RNA-targeting medicines
5 Roche announces definitive agreement to acquire Seragon Pharmaceuticals
6 Roche Children's Walk 2014
7 Roche with good start in 2014
8 Roche delivers strong 2013 results
9 Roche and Polyphor join efforts to combat multi-drug-resistant bacterial infections
10 Roche posts strong sales growth in the first nine months of 2013
11 Roche inaugurates Translational and Clinical Research Center at the Alexandria Center for Life Science in New York City
12 Christoph Franz nominated to become new Roche Chairman
13 Roche halts investigation of aleglitazar
14 Roche Group posts strong sales growth in the first quarter
15 Roche launches new process for accessing clinical trial data
16 FDA approves Roche's Kadcyla (trastuzumab emtansine), the first antibody-drug conjugate for treating HER2-positive metastatic breast cancer
17 Roche delivers strong 2012 results
18 Roche reports positive studies of MabThera given by subcutaneous injection
19 Roche and the Innovative Medicines Initiative join forces to promote use of Nobel Prize-winning stem cell technology
20 Results from the positive phase III AVAglio study
World Pharma News RSS Channel
Subscribe to World Pharma News by Email

Follow/Join us on:   Facebook   Twitter   XING   LinkedIn   Google Groups    FeedBurner

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]